Are there any side effects of BPC 157?

BPC 157, while noted for its potential benefits, also carries significant concerns regarding side effects. Here are the key points discussed by Andrew Huberman:

1. Angiogenesis and Tumor Risk: BPC 157 promotes angiogenesis by increasing vascular endothelial growth factor (VEGF) levels. This mechanism is similar to that of certain cancer treatments that inhibit VEGF to reduce tumor size. Therefore, there is a concern that using BPC 157 could potentially stimulate tumor growth or exacerbate existing cancer risks due to its angiogenic properties 1.

2. Lack of Human Data: Despite animal studies showing promising results for tissue repair, there is a significant lack of data on the long-term effects of BPC 157 in humans. This absence of substantial human research underscores the potential risks involved in its use 1.

3. Dosage and Monitoring: Users are generally advised to take the minimal effective dosage of BPC 157 (typically 300 to 500 micrograms, 2-3 times a week). Continuous use or higher dosages are discouraged, as they could increase the risks associated with angiogenesis, including potential cancer development. Monitoring one's health metrics for any signs of tumor growth is strongly recommended 1.

In summary, while BPC 157 might offer recovery benefits, the risks of tumor stimulation and lack of thorough human research necessitate caution and responsible usage.